Galderma Investigational Site
Peterborough K9J
0 studies enrolling now · 2 studies all time
What they study most
Acne Vulgaris, Atopic Dermatitis
Studies at this site
Dose-ranging Study of Nemolizumab in Atopic Dermatitis
— Completed
Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris
— Completed